2014 Course Description
The United Mitochondrial Disease Foundation, the Mitochondrial Medicine Society, the Mitochondria Research Society, the Mitochondrial Physiology Society, and Northeast Ohio Medical University have joined efforts to sponsor and organize another multidisciplinary symposium. Mitochondrial diseases are more common than previously recognized, and mitochondrial pathophysiology is now a recognized part of many disease processes, including heart disease, cancer, AIDS and diabetes. There have been significant advances in the molecular genetics, proteomics, epidemiology and clinical aspects of mitochondrial pathophysiology. This conference is directed toward the scientist and clinician interested in all aspects of mitochondrial science.
The content of this educational program was determined by rigorous assessment of educational needs and includes surveys, program feedback, expert faculty assessment, literature review, medical practice, chart review and new medical knowledge. The format will include didactic lectures from invited experts intermixed with peer-reviewed platform presentations. There will be ample time for professional discussion both in and out of the meeting room, and peer-reviewed poster presentations will be given throughout the meeting. This will be a four-day scientific meeting aimed at those with scientific and clinical interests.
Scientists, physicians (Neurologists, Geneticists, Pediatrics/Generalists, Nephrologists, Cardiologists, Endocrinologists), nurses, physician assistants, advanced practice nurses, genetic counselors and allied health professionals.
At the end of the scientific program, attendees will have an in-depth understanding of the following areas - note that each session will have a learning objective outlined in the course syllabus:
- Articulate the current principles of mitochondrial and nuclear DNA mutation information specific to human disease, focusing on the current and future state of NextGen genetic testing.
- Explain the current knowledge base for pathogenic mechanisms of mitochondrial diseases and the impact of the modern pharmacopeia on mitochondrial function and dysfunction.
- Describe the evolving field of mitochondrial proteomics, including detailed focus on the mitochondrial ribosomes and the mitochondrial polymerase and systems biology as they relate to mitochondrial physiology and disease.
- Utilize the current standards of diagnostic testing for mitochondrial diseases.
- Integrate mitochondrial biochemistry, physiology and dynamics and relate these to the pathophysiology of mitochondrial disease.
- Apply new pharmacological approaches to mitochondrial disorders, based on recognition of the mechanism of action for novel medications that may improve mitochondrial energy production and reduce oxidative stress.
Speakers are leaders in the study of mitochondria from around the world. Attendees will be exposed to new ideas and concepts that will be valuable to both researchers and clinicians.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE); through the co/joint sponsorship of Northeast Ohio Medical University and the United Mitochondrial Disease Foundation. Northeast Ohio Medical University is accredited by the ACCME and ACPE to provide continuing education for physicians and pharmacists.
Northeast Ohio Medical University designates this Live activity for a maximum of ____ AMA PRA Category I CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.